Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

ObjectivEye

Explore full profile

Future-proof hiring with compliant, skills-based AI that’s explainable and inclusive

The Hague, NetherlandsFounded 2025Jobs Recruitment
Valuation $0–100M Latest valuation · 2025
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for ObjectivEye and the history behind them.

About ObjectivEye

ObjectivEye develops a scalable, AI-driven recruitment platform that helps organizations significantly reduce the annual loss of €1.2–2.5 million per 100 hires caused by mismatches and attrition. By getting hiring right the first time, employers achieve an average saving of €955K. Instead of relying on experience and job titles, ObjectivEye leverages international skills standards and competency profiles. This expands the talent pool, improves job matching, and enables future-proof, skills-based hiring. The platform is distinguished by explainable and reliable AI, fully aligned with the EU AI Act and NIS2, making it immediately applicable in regulated sectors. It combines speed, transparency, and compliance with inclusive and ethical recruitment. By facilitating talent mobility and enabling employers to anticipate evolving roles and skill needs, ObjectivEye empowers organizations to build a sustainable and resilient workforce.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2025
Headquarters
The Hague, Netherlands
Employees
7
Open positions
1
Dealroom signal
85.0/100
Industry
Jobs Recruitment
Sector
Jobs Recruitment, Human Resources, Recruitment, Core AI, Spinout, Recruitment Efficiency, Sustainable Development Goals, Recruitment Enabler, Woman Founder, AI Applications
Technology
Artificial Intelligence
Business model
SaaS
Client focus
b2b

Latest news

Press, funding announcements and product moves mentioning ObjectivEye.

See all news

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
CONVERTIBLEEquity / VC Aug 2025 $385K UNIIQ
SPINOUTOther financing Oct 2024 $25M TNO - Netherlands Organisation for Applied Scientific Research
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

ObjectivEye website traffic

Latest recorded traffic for ObjectivEye is 40 monthly website visits, down 92.2% over the last three months. ObjectivEye's team grew 40% over the past year.

Latest monthly visits40 3-month web change-92.2% 1-year team growth+40%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • UNIIQ

Other known investors1 additional known investor

  • TNO - Netherlands Organisation for Applied Scientific Research
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇳🇱 Netherlands · The Hague HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about ObjectivEye on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See ObjectivEye’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.